Ann S. Kim

499 total citations
9 papers, 355 citations indexed

About

Ann S. Kim is a scholar working on Internal Medicine, Oncology and Immunology. According to data from OpenAlex, Ann S. Kim has authored 9 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Internal Medicine, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Ann S. Kim's work include Venous Thromboembolism Diagnosis and Management (3 papers), Immune Response and Inflammation (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ann S. Kim is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (3 papers), Immune Response and Inflammation (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ann S. Kim collaborates with scholars based in United States, India and Taiwan. Ann S. Kim's co-authors include Alok A. Khorana, Keith R. McCrae, Bicky Thapa, Susan K. Pierce, Pauline Funchain, Munir Akkaya, Mirna Peña, Brian P. Hobbs, Lorenzo Gervaso and Louis H. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Ann S. Kim

9 papers receiving 353 citations

Peers

Countries citing papers authored by Ann S. Kim

Since Specialization

Citations

This map shows the geographic impact of Ann S. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann S. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann S. Kim more than expected).

Fields of papers citing papers by Ann S. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann S. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann S. Kim. The network helps show where Ann S. Kim may publish in the future.

Co-authorship network of co-authors of Ann S. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ann S. Kim. A scholar is included among the top collaborators of Ann S. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann S. Kim. Ann S. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura 2022 ·Blood ·(unknown), Ann S. Kim, Senthil Sukumar, Marshall Mazepa, (unknown), Evan M. Braunstein, Robert A. Brodsky, Spero R. Cataland, Shruti Chaturvedi	10
2	Increased incidence of venous thromboembolism with cancer immunotherapy 2021 ·Med ·(unknown), Shadi Swaidani, Ann S. Kim, Bicky Thapa, Lorenzo Gervaso, Brian P. Hobbs, Wei Wei, Tyler Alban, Pauline Funchain, Suman Kundu, Naseer Sangwan, Patricia Rayman, Paul G. Pavicic, C. Marcela Díaz‐Montero, John Barnard, Keith R. McCrae, Alok A. Khorana	84
3	Mechanisms and biomarkers of cancer-associated thrombosis 2020 ·Translational research ·Ann S. Kim, Alok A. Khorana, Keith R. McCrae	64
4	Identifying miRNA Biomarkers and Predicted Targets Associated with Venous Thromboembolism in Colorectal Cancer Patients 2019 ·Blood ·Ann S. Kim, Matthew F. Kalady, Jennifer DeVecchio, Kahraman Tanrıverdi, Jane E. Freedman, John Barnard, Tae Hyun Hwang, Alok A. Khorana, Keith R. McCrae	8
5	Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI). 2019 ·Journal of Clinical Oncology ·Bicky Thapa, (unknown), Ann S. Kim, Lorenzo Gervaso, Pradnya D. Patil, Cassandra Calabrese, Alok A. Khorana, Pauline Funchain	29
6	Toll-like receptor 9 antagonizes antibody affinity maturation 2018 ·Nature Immunology ·Munir Akkaya, Billur Akkaya, Ann S. Kim, Pietro Miozzo, Haewon Sohn, Mirna Peña, Alexander S. Roesler, Brandon Theall, (unknown), Juraj Kabát, Jinghua Lu, David W. Dorward, Eric Dahlstrom, Jeff Skinner, Louis H. Miller, Susan K. Pierce	47
7	Venous Thromboembolism in Cancer Patients Receiving Immunotherapy 2018 ·Blood ·(unknown), Ann S. Kim, Bicky Thapa, Brian P. Hobbs, Alok A. Khorana	21
8	B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids 2017 ·The Journal of Immunology ·Munir Akkaya, Billur Akkaya, Pietro Miozzo, (unknown), Mirna Peña, Patrick W. Sheehan, Ann S. Kim, Olena Kamenyeva, Juraj Kabát, Silvia Bolland, Akanksha Chaturvedi, Susan K. Pierce	24
9	Targeting glutamine metabolism rescues mice from late-stage cerebral malaria 2015 ·Proceedings of the National Academy of Sciences ·Emile B. Gordon, Geoffrey T. Hart, Tuan M. Tran, Michael Waisberg, Munir Akkaya, Ann S. Kim, Sara E. Hamilton, Mirna Peña, Takele Yazew, Chen‐Feng Qi, (unknown), Ying-Chun Lo, Louis H. Miller, Jonathan D. Powell, Susan K. Pierce	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact